Retrospective Evaluation of the Results of Low-Dose Intravenous Thrombolytic Therapy in Acute Ischemic Stroke.

Intracranial hemorrhage ischemic stroke thrombolytic therapy

Journal

Sisli Etfal Hastanesi tip bulteni
ISSN: 1302-7123
Titre abrégé: Sisli Etfal Hastan Tip Bul
Pays: Turkey
ID NLM: 9424130

Informations de publication

Date de publication:
2023
Historique:
received: 01 11 2022
revised: 01 04 2023
accepted: 05 04 2023
medline: 30 10 2023
pubmed: 30 10 2023
entrez: 30 10 2023
Statut: epublish

Résumé

This study aimed to investigate the clinical data of patients with acute ischemic stroke who received low-dose intravenous (IV) thrombolytic therapy (0.9 mg/kg; maximum 50 mg) for various reasons, compare the obtained results with those of patients who received standard-dose thrombolytic therapy, and discuss them in light of the literature. Patients who received IV thrombolytic therapy within 4.5 h of symptom onset between January 2015 and June 2018 were retrospectively reviewed. Patients were divided into the low-dose group (0.9 mg/kg; max. 50 mg) and the standard-dose group (0.9 mg/kg; max 90 mg) according to the thrombolytic therapy dose, after which demographic data and clinical results were analyzed. A total of 109 patients receiving thrombolytic therapy (19 patients in the low-dose group and 90 patients in the standard-dose group) were included in the study. There was no significant difference between the two groups in terms of good outcome rates (47.4% vs. 52.2%). There was no statistically significant difference in terms of symptomatic and asymptomatic intracerebral hemorrhage rates. Our study showed similar efficacy and safety for low-dose IV thrombolytic therapy compared with standard-dose IV thrombolytic therapy administered within 4.5 h of symptom onset in patients with acute ischemic stroke.

Identifiants

pubmed: 37900337
doi: 10.14744/SEMB.2023.51437
pii: SEMB-57-359
pmc: PMC10600607
doi:

Types de publication

Journal Article

Langues

eng

Pagination

359-366

Informations de copyright

©Copyright 2023 by The Medical Bulletin of Sisli Etfal Hospital.

Déclaration de conflit d'intérêts

None declared.

Références

Stroke. 2006 Jul;37(7):1810-5
pubmed: 16763187
Lancet. 1991 Jun 22;337(8756):1521-6
pubmed: 1675378
J Vasc Interv Radiol. 2019 Feb;30(2):134-140
pubmed: 30717945
J Neuroimaging. 2011 Apr;21(2):113-20
pubmed: 19909396
Medicine (Baltimore). 2017 Dec;96(51):e9435
pubmed: 29390574
Lancet. 2014 Nov 29;384(9958):1929-35
pubmed: 25106063
J Clin Neurosci. 2009 Oct;16(10):1276-8
pubmed: 19570685
Sci Rep. 2016 Aug 11;6:31344
pubmed: 27510959
J Stroke Cerebrovasc Dis. 2013 Jul;22(5):690-3
pubmed: 23111010
BMC Neurol. 2021 Nov 9;21(1):434
pubmed: 34753432
CNS Neurosci Ther. 2015 Aug;21(8):657-61
pubmed: 26096605
J Stroke Cerebrovasc Dis. 2016 Oct;25(10):2543-8
pubmed: 27444521
Stroke. 2015 Sep;46(9):2541-8
pubmed: 26243232
J Stroke Cerebrovasc Dis. 2018 Dec;27(12):3587-3590
pubmed: 30217636
Circulation. 2017 Mar 14;135(11):1024-1035
pubmed: 28119380
Stroke. 2009 Nov;40(11):3591-5
pubmed: 19762694
Drug Des Devel Ther. 2020 Jan 17;14:257-263
pubmed: 32021109
Lancet. 2020 Jul 11;396(10244):129-142
pubmed: 32653056
Int J Stroke. 2015 Jul;10(5):778-88
pubmed: 25832995
Acta Neurol Scand. 2018 Mar;137(3):347-355
pubmed: 29218699
Stroke. 2016 Feb;47(2):581-641
pubmed: 26696642
Clin Neurol Neurosurg. 2007 Sep;109(7):567-70
pubmed: 17573188
Postgrad Med. 2000 May 15;107(6):85-6, 89-93
pubmed: 10865869
Neurologia (Engl Ed). 2022 Mar;37(2):130-135
pubmed: 35279226
Cerebrovasc Dis. 2011;31(2):123-9
pubmed: 21088392
N Engl J Med. 1995 Dec 14;333(24):1581-7
pubmed: 7477192
J Neurol Sci. 2019 Apr 15;399:76-81
pubmed: 30780072
Int J Stroke. 2014 Dec;9(8):1117-24
pubmed: 25088843
Ann Indian Acad Neurol. 2018 Jul-Sep;21(3):214-219
pubmed: 30258265
Stroke. 2018 Mar;49(3):e46-e110
pubmed: 29367334
Postgrad Med. 1998 Apr;103(4):221-4, 229-31
pubmed: 9553597
JAMA Neurol. 2014 Sep;71(9):1181-5
pubmed: 25069522
J Stroke Cerebrovasc Dis. 2018 Feb;27(2):381-390
pubmed: 29111341
Expert Rev Neurother. 2013 Aug;13(8):895-902
pubmed: 23965163
Stroke. 2010 Sep;41(9):1984-9
pubmed: 20651262
Stroke. 2014 Aug;45(8):2354-8
pubmed: 25013020
Stroke. 2017 Sep;48(9):2605-2609
pubmed: 28739832
N Engl J Med. 2016 Jun 16;374(24):2313-23
pubmed: 27161018

Auteurs

Mustafa Cetiner (M)

Department of Neurology, Kutahya Health Sciences University Faculty of Medicine, Kutahya, Türkiye.

Neslihan Eskut (N)

Department of Neurology, Health Science University Bozyaka Education and Research Hospital, Izmir, Türkiye.

Gonul Akdag (G)

Department of Neurology, Kutahya Health Sciences University Faculty of Medicine, Kutahya, Türkiye.

Fatma Akkoyun Arikan (FA)

Department of Neurology, Kutahya Health Sciences University Faculty of Medicine, Kutahya, Türkiye.

Merve Guler (M)

Department of Neurology, Kutahya Health Sciences University Faculty of Medicine, Kutahya, Türkiye.

Sibel Canbaz Kabay (SC)

Department of Neurology, Kutahya Health Sciences University Faculty of Medicine, Kutahya, Türkiye.
Current affiliation: Department of Neurology, Dokuz Eylul University Faculty of Medicine, Izmir, Türkiye.

Classifications MeSH